| Guidelines for management of ischaemic stroke and transient ischaemic attack 2008 European Stroke Organisation (ESO) Executive Committee, ... Cerebrovascular diseases 25 (5), 457-507, 2008 | 2393 | 2008 |
| Blood pressure and clinical outcomes in the International Stroke Trial J Leonardi-Bee, PMW Bath, SJ Phillips, PAG Sandercock Stroke 33 (5), 1315-1320, 2002 | 1491 | 2002 |
| Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke RL Sacco, HC Diener, S Yusuf, D Cotton, S Ôunpuu, WA Lawton, ... New England Journal of Medicine 359 (12), 1238-1251, 2008 | 1370 | 2008 |
| Platelet size: measurement, physiology and vascular disease PMW Bath, RJ Butterworth Blood coagulation & fibrinolysis 7 (2), 157-161, 1996 | 1321 | 1996 |
| Telmisartan to prevent recurrent stroke and cardiovascular events S Yusuf, HC Diener, RL Sacco, D Cotton, S Ôunpuu, WA Lawton, ... New England Journal of Medicine 359 (12), 1225-1237, 2008 | 1124 | 2008 |
| European Stroke Initiative recommendations for stroke management--update 2003. W Hacke Cerebrovascular Diseases 16 (4), 2003 | 1049 | 2003 |
| Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review P Rashid, J Leonardi-Bee, P Bath Stroke 34 (11), 2741-2748, 2003 | 994 | 2003 |
| High blood pressure in acute stroke and subsequent outcome: a systematic review M Willmot, J Leonardi-Bee, PMW Bath Hypertension 43 (1), 18-24, 2004 | 950 | 2004 |
| Vascular dysfunction—the disregarded partner of Alzheimer's disease MD Sweeney, A Montagne, AP Sagare, DA Nation, LS Schneider, ... Alzheimer's & Dementia 15 (1), 158-167, 2019 | 775 | 2019 |
| Influence of platelet size on outcome after myocardial infarction JF Martin, PMW Bath, ML Burr The Lancet 338 (8780), 1409-1411, 1991 | 771 | 1991 |
| Interventions for dysphagia and nutritional support in acute and subacute stroke C Geeganage, J Beavan, S Ellender, PMW Bath Cochrane Database of Systematic Reviews, 2012 | 731* | 2012 |
| Action plan for stroke in Europe 2018–2030 B Norrving, J Barrick, A Davalos, M Dichgans, C Cordonnier, A Guekht, ... European stroke journal 3 (4), 309-336, 2018 | 697 | 2018 |
| The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial EC Sandset, PMW Bath, G Boysen, D Jatuzis, J Kõrv, S Lüders, ... The Lancet 377 (9767), 741-750, 2011 | 696 | 2011 |
| Publication bias in reports of animal stroke studies leads to major overstatement of efficacy ES Sena, HB Van Der Worp, PMW Bath, DW Howells, MR Macleod PLoS biology 8 (3), e1000344, 2010 | 676 | 2010 |
| Primary stroke prevention worldwide: translating evidence into action MO Owolabi, AG Thrift, A Mahal, M Ishida, S Martins, WD Johnson, ... The Lancet Public Health 7 (1), e74-e85, 2022 | 615 | 2022 |
| Post-stroke dysphagia: a review and design considerations for future trials DL Cohen, C Roffe, J Beavan, B Blackett, CA Fairfield, S Hamdy, ... International Journal of Stroke 11 (4), 399-411, 2016 | 597 | 2016 |
| Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators The Lancet 363 (9407), 439-445, 2004 | 589 | 2004 |
| Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease P Bath, C Algert, N Chapman, B Neal Stroke 35 (3), 622-626, 2004 | 577 | 2004 |
| Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke CS Anderson, T Robinson, RI Lindley, H Arima, PM Lavados, TH Lee, ... New England Journal of Medicine 374 (24), 2313-2323, 2016 | 569 | 2016 |
| Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission VL Feigin, MO Owolabi, F Abd-Allah, RO Akinyemi, NV Bhattacharjee, ... The Lancet Neurology 22 (12), 1160-1206, 2023 | 559 | 2023 |
Nikola SpriggUniversity of NottinghamVerified email at nottingham.ac.uk
